Organovo Holdings Inc News - ONVO

Professional-Grade Tools, for Individual Investors.

Premium

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]

Form 8-K - Current report

Organovo Highlights FXR314 Near Term Value Catalysts at Jones Trading Conference Strong Preclinical and Human Rationale for FXR314 in P2 2 Ulcerative Colitis

SAN DIEGO, July 16, 2024 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq:ONVO), a clinical stage...

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Organovo Data Presented at Digestive Disease Week (DDW2024) Demonstrating Potential for FXR314 as Combination Therapy with Tofacitinib for Inflammatory Bowel Disease

SAN DIEGO, May 21, 2024 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq:ONVO), a clinical stage...

Form 424B4 - Prospectus [Rule 424(b)(4)]

Organovo to Present Data on FXR314 at Digestive Diseases Week (DDW2024)

SAN DIEGO, May 14, 2024 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq:ONVO), a clinical stage...

Form 8-K - Current report

LORTAP KCOTS 3 weeks ago

Wasn’t this way up when woods was all in?

👍️0

Monksdream 3 weeks ago

ONVO new 52 week low

👍️0

TheFinalCD 4 months ago

here is a better place to talk MMA https://investorshub.advfn.com/Mixed-Martial-Arts-MMA-UFC-Bellator-K-1-Glory-et-22925

👍️0

TrendTrade2016 4 months ago

ILIA IS A BAD ASS WITH BRILLIANT BOXING AND GROUND SKILLS...NOBODY IN HIS DIVISION WILL BEAT HIM FOR MANY MOONS

👍️0

TheFinalCD 4 months ago

👍️0

stock1ace1 4 months ago

Flush!

👍️0

TrendTrade2016 4 months ago

He better stay away fro Ilia

👍️0

TheFinalCD 4 months ago

that was wild, highlight reel for the record books

👍️0

TheFinalCD 4 months ago

S-1 Offering
April 2024 S-1 Offering (size undisclosed)
EDGAR
In Progress

Anticipated Deal Size
$10,000,000
Status
In Progress
https://dilutiontracker.com/app/search/ONVO?a=dbb88c

1.59

👍️0

TrendTrade2016 4 months ago

Did you watch max get lucky over the weekend with his pathetic right. Wait until Ilia gets a hold of that little guy. He won’t last 2 minutes.

👍️0

TheFinalCD 4 months ago

woaaah

TrendTrade2016

Member Level
Re: None

Monday, April 15, 2024 8:47:13 AM

Post#
10478
of 10478
Change your lifestyle and stop drinking so much alcohol and then maybe you won’t have fatty liver. Go on a fast ya fat slobs to give your liver a rest. Stop eating junk food filled with fructose. Smh

👍️0

TrendTrade2016 4 months ago

Change your lifestyle and stop drinking so much alcohol and then maybe you won’t have fatty liver. Go on a fast ya fat slobs to give your liver a rest. Stop eating junk food filled with fructose. Smh

👍️0

Awl416 4 months ago

Organovo Announces Positive Phase 2 Results for FXR314 in Metabolic Dysfunction-Associated Steatohepatitis (MASH) Showing Both Reduction in Liver Fat Content and Strong Safety and Tolerability Compared to Placebo

👍️0

RandolRocketman 5 months ago

Still hodling these ONVO hoping SpaceX buys them out and then it's "To da moon!"

👍️0

Monksdream 6 months ago

ONVO under $2

👍️0

glenn1919 6 months ago

ONVO.................................https://stockcharts.com/h-sc/ui?s=ONVO&p=W&b=5&g=0&id=p86431144783

👍️0

Monksdream 7 months ago

ONVO new 52 week low

👍️0

phytokaiser1 10 months ago

From new 10Q. They dropped their burn rate a little more. Looking like 6 months of cash on hand starting Oct 1. They will need money before their new target data.

Date Cash Burn Rate
Friday, March 31, 2023 $15,301
Friday, June 30, 2023 $10,754 $4,547
Saturday, September 30, 2023 $7,617 $3,137

👍️0

81vette 10 months ago

Not looking good with volume fading

👍️0

phytokaiser1 10 months ago

I mean july-september

👍️0

phytokaiser1 10 months ago

That was for april-june. Published in August. Should see another 10q any day now for july-august. Maybe only another 3 months left from now

👍️0

81vette 10 months ago

6 months until cash runs out at current rate,or become profitable,or raise more cash via loan or create and sell shares

👍️0

phytokaiser1 10 months ago

Looks like about 5m a quarter...

Cash and cash equivalents
June 30, 2023 $10,754
March 31, 2023 $15,301

👍️0

81vette 10 months ago

I think your right,latest 10k show’s employee stock program approved,10.75M cash on hand,look at latest quarterly to see cash used to figure burn rate,they have no revenue yet unfortunately, FINVIS might show a burn rate(lots of great info,I use it often,scanner is best I have ever used,lots of factors)

👍️ 1

phytokaiser1 10 months ago

Might be the employees purchasing stock or the company. Their employee stock program was just passed.

What I want to know is what their burn rate is in cash. Anyone know how to calculate that?

👍️0

81vette 10 months ago

Buying volume up 55Xs ave today,10 day ave vol up 11Xs

👍️0

81vette 10 months ago

Product is world changing,it will get found

👍️0

81vette 10 months ago

Predictable Bullish chart,no news YET! Loaded and holding for it,under the radar with all the big runners today getting chased

👍️0

Monksdream 10 months ago

ONVO under $2

👍️0

phytokaiser1 10 months ago

Updated Investor Presentation.

https://ir.organovo.com/static-files/3e5d2de6-6ca0-4404-a527-dbdc4461e0f0

Anyone know how much cash they have and what their burn rate is?

👍️0

Monksdream 11 months ago

ONVO under $2

👍️0

phytokaiser1 11 months ago

HC Wainwright Presentation up. ONVO management is now moving.

https://ir.organovo.com/investor-presentations

👍️0

LORTAP KCOTS 11 months ago

Almost back down below a buck..

👍️0

phytokaiser1 11 months ago

First presentation update in 2 years.

https://ir.organovo.com/investor-presentations

They have drastically changed their business model in the last 5 years. They are a full on drug company now.

👍️0

glenn1919 2 years ago

ONVO...........................https://stockcharts.com/h-sc/ui?s=ONVO&p=W&b=5&g=0&id=p86431144783

👍️0

starbuxsux 2 years ago

this needs to get pumped by Redditors

👍️0

phytokaiser1 2 years ago

When it reaches 72$/share, I'll have fun lol

👍️0

Awl416 2 years ago

I’m having fun… anyone else?

Or turn the lights off lol

👍️0

Awl416 2 years ago

Back over 2.65 heats up

👍️0

tw0122 2 years ago

Took some $1.90s and $2.10s premarket yesterday here but still holding premarket today. On watch another low floater

👍️0

eddyimano 2 years ago

Everyone got out of this already? ONVO had a good day today!

👍️0

eddyimano 2 years ago

It is showing some life here today. 10Q is out. I believe that is the reason.

👍️0

eddyimano 2 years ago

-10/5/22 they held 1.416M shares at around $9 per share.

-They start unload since 1/6/21-3/30/21 for 929,307 shares.

-during that time it hit as high as $23 per share.

-after that, they are keeping unloading a little by little.

-as of 9/30/22, they still hold 271,860 shares.

-I wish I could send picture of what they did.

*IMO, they will keep unloading slowly and most likely, they will sell everything. ONVO was high risk, high return. Now IT IS “HIGHER RISK, HIGHER RETURN.” My wife needs liver transplant, I am hoping this company to do well, so whether risky or not, I bought some and holding. I am praying.

👍️0

LORTAP KCOTS 2 years ago

This one still held by Cathie Wood?

👍️0

TheFinalCD 2 years ago

and down it goes

should have never seen 5's on todays news

👍️0

TheFinalCD 2 years ago

+19% from +120%

thats just crazy

wonder what this does at the open and rest of the day

👍️0

TheFinalCD 2 years ago

thats the dirty mm's and whoever else hyper extends these pops

+120% on todays news is just a joke

just goes to show how easily stocks are manipulated

especially low floaters

https://finviz.com/quote.ashx?t=ONVO&ty=c&ta=1&p=d

👍️0

dirkv 2 years ago

Pre-Market High $5.02 (04:11:14 AM) = +120%

volume already more than 1 million.

👍️0

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Organovo Holdings Inc (ONVO)

Professional-Grade Tools, for Individual Investors.

ONVO News

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]

Form 8-K - Current report

Organovo Highlights FXR314 Near Term Value Catalysts at Jones Trading Conference Strong Preclinical and Human Rationale for FXR314 in P2 2 Ulcerative Colitis

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Organovo Data Presented at Digestive Disease Week (DDW2024) Demonstrating Potential for FXR314 as Combination Therapy with Tofacitinib for Inflammatory Bowel Disease

Form 424B4 - Prospectus [Rule 424(b)(4)]

Organovo to Present Data on FXR314 at Digestive Diseases Week (DDW2024)

Form 8-K - Current report

ONVO Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Organovo Holdings Inc (ONVO) News

Organovo Holdings Inc (ONVO)

Professional-Grade Tools, for Individual Investors.

ONVO News

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]

Form 8-K - Current report

Organovo Highlights FXR314 Near Term Value Catalysts at Jones Trading Conference Strong Preclinical and Human Rationale for FXR314 in P2 2 Ulcerative Colitis

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Organovo Data Presented at Digestive Disease Week (DDW2024) Demonstrating Potential for FXR314 as Combination Therapy with Tofacitinib for Inflammatory Bowel Disease

Form 424B4 - Prospectus [Rule 424(b)(4)]

Organovo to Present Data on FXR314 at Digestive Diseases Week (DDW2024)

Form 8-K - Current report

ONVO Discussion

Your Recent History